Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Mendelian analysis links coffee drinking to lower kidney stone risk
Genetic data provide evidence that drinking coffee or caffeine intake in high amounts may cause a reduction in the risk of kidney stones, as shown in a study.
Mendelian analysis links coffee drinking to lower kidney stone risk
26 Oct 2021Depression negatively affects semen quality
Men with depression appear to have poor semen quality parameters, including volume, concentration, count, and motility, a study has found. Furthermore, the association between depression and semen quality does not seem to be mediated by oxidative stress.
Depression negatively affects semen quality
23 Oct 2021Moderate physical activity protective against incontinence in women
Women who spend greater time participating in moderate physical activity are at lower risk of developing stress, urge, and mixed incontinence, as suggested in a recent study.
Moderate physical activity protective against incontinence in women
20 Oct 2021Kidney stone disease prevalent among people with disabilities
Nephrolithiasis appears to be common among people with disabilities (PWDs), such that one in three people who have the kidney stone disease is a PWD, as reported in a study from the US.
Kidney stone disease prevalent among people with disabilities
10 Oct 2021Neurovascular bundle sparing boosts postoperative sexual function in prostate cancer patients
The width of the spared neurovascular bundle (NVB) is an important indicator of postoperative sexual function after robot-assisted laparoscopic prostatectomy for prostate cancer, a recent study has found. These findings point to NVB as an easy intraoperative marker for assessing postoperative outcomes.
Neurovascular bundle sparing boosts postoperative sexual function in prostate cancer patients
08 Oct 2021ADT-docetaxel-abiraterone: A winning combo for mCSPC
Triplet therapy combining androgen deprivation therapy (ADT), docetaxel, and abiraterone-prednisone improves overall survival (OS) in men with de novo metastatic castration-sensitive prostate cancer (mCSPC), according to results of the phase III PEACE-1 trial presented at ESMO 2021.